Venous thromboembolism prophylaxis for major general surgery: a review of the clinical effectiveness and guidelines

Canadian Agency for Drugs and Technologies in Health
Record ID 32011001024
Authors' recommendations: Limited evidence suggests that extending thromboprophylaxis with LMWH post-discharge may be beneficial in some high-risk patients after major abdominal or pelvic surgery for cancer, but further research is needed to determine optimal timeframe and safety. Current guidelines state that extended thromboprophylaxis may be considered in select high-risk patients including those who have had major surgery for cancer in the abdomen or pelvis.
Project Status: Completed
Year Published: 2011
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Humans
  • Surgical Procedures, Operative
  • Venous Thromboembolism
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
Contact Email:
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.